International Journal of Cardiovascular ResearchISSN: 2324-8602

Reach Us +1 850 900 2634

Case Report, Int J Cardiovasc Res Vol: 4 Issue: 6

Extreme Coumadin Resistance in a patient with atrial fibrillation and End Stage Renal Disease

Hussain Ibrahim1*, Nashmia Riaz1 and Bohuslav Finta2
1Grand Rapids Medical Education Partners, Michigan State University,Michigan, USA
2Spectrum Health Medical Group Cardiovascular Services, Michigan, USA
Corresponding author : Hussain Ibrahim
3339 Juniper Dr NW Apt 3b, Grand Rapids, MI, USA
Tel: 616 881 2280
E-mail: [email protected]
Received: May 05, 2015 Accepted: July 04, 2015 Published: July 09, 2015
Citation: Ibrahim H, Riaz N, Finta B (2015) Extreme Coumadin Resistance in a patient with atrial fibrillation and End Stage Renal Disease. Int J Cardiovasc Res 4:6. doi:10.4172/2324-8602.1000236

Abstract

Extreme Coumadin Resistance in a patient with atrial fibrillation and End Stage Renal Disease

Warfarin resistance is a rare condition and its prevalence is less than 0.1%. It is defined as a daily Coumadin requirement of more than 15mg or a weekly requirement of more than 70mg in order to maintain a therapeutic INR.

Keywords: Coumadin Resistance, Atrial fibrillation, End Stage Renal Disease

Track Your Manuscript

Share This Page

Media Partners